Logo image of OM

OUTSET MEDICAL INC (OM) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:OM - US6901452069 - Common Stock

3.62 USD
+0.08 (+2.26%)
Last: 12/30/2025, 8:00:02 PM
3.6006 USD
-0.02 (-0.54%)
After Hours: 12/30/2025, 8:00:02 PM
Fundamental Rating

2

Taking everything into account, OM scores 2 out of 10 in our fundamental rating. OM was compared to 186 industry peers in the Health Care Equipment & Supplies industry. OM has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, OM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year OM has reported negative net income.
OM had a negative operating cash flow in the past year.
In the past 5 years OM always reported negative net income.
In the past 5 years OM always reported negative operating cash flow.
OM Yearly Net Income VS EBIT VS OCF VS FCFOM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -31.80%, OM is in line with its industry, outperforming 40.86% of the companies in the same industry.
OM has a Return On Equity of -61.93%. This is comparable to the rest of the industry: OM outperforms 46.77% of its industry peers.
Industry RankSector Rank
ROA -31.8%
ROE -61.93%
ROIC N/A
ROA(3y)-47.4%
ROA(5y)-38.06%
ROE(3y)-228.02%
ROE(5y)-148.69%
ROIC(3y)N/A
ROIC(5y)N/A
OM Yearly ROA, ROE, ROICOM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

OM has a worse Gross Margin (37.70%) than 69.89% of its industry peers.
OM's Gross Margin has improved in the last couple of years.
OM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y66.06%
GM growth 5YN/A
OM Yearly Profit, Operating, Gross MarginsOM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

3

2. Health

2.1 Basic Checks

OM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OM has more shares outstanding
OM has more shares outstanding than it did 5 years ago.
The debt/assets ratio for OM is higher compared to a year ago.
OM Yearly Shares OutstandingOM Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
OM Yearly Total Debt VS Total AssetsOM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

OM has an Altman-Z score of -4.95. This is a bad value and indicates that OM is not financially healthy and even has some risk of bankruptcy.
OM has a Altman-Z score of -4.95. This is in the lower half of the industry: OM underperforms 70.43% of its industry peers.
A Debt/Equity ratio of 0.67 indicates that OM is somewhat dependend on debt financing.
OM's Debt to Equity ratio of 0.67 is on the low side compared to the rest of the industry. OM is outperformed by 65.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Altman-Z -4.95
ROIC/WACCN/A
WACC5.93%
OM Yearly LT Debt VS Equity VS FCFOM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

OM has a Current Ratio of 7.09. This indicates that OM is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 7.09, OM belongs to the best of the industry, outperforming 87.10% of the companies in the same industry.
A Quick Ratio of 5.77 indicates that OM has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 5.77, OM belongs to the top of the industry, outperforming 86.02% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.09
Quick Ratio 5.77
OM Yearly Current Assets VS Current LiabilitesOM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 65.94% over the past year.
The Revenue has been growing slightly by 4.65% in the past year.
OM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 49.74% yearly.
EPS 1Y (TTM)65.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.21%
Revenue 1Y (TTM)4.65%
Revenue growth 3Y3.48%
Revenue growth 5Y49.74%
Sales Q2Q%2.67%

3.2 Future

Based on estimates for the next years, OM will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.67% on average per year.
OM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.63% yearly.
EPS Next Y82.99%
EPS Next 2Y37.79%
EPS Next 3Y24.04%
EPS Next 5Y14.67%
Revenue Next Year3.61%
Revenue Next 2Y6.33%
Revenue Next 3Y4.68%
Revenue Next 5Y11.63%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
OM Yearly Revenue VS EstimatesOM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
OM Yearly EPS VS EstimatesOM Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -20 -40 -60 -80

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

OM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OM Price Earnings VS Forward Price EarningsOM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OM Per share dataOM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

A more expensive valuation may be justified as OM's earnings are expected to grow with 24.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.79%
EPS Next 3Y24.04%

More info and screens

0

5. Dividend

5.1 Amount

OM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

OUTSET MEDICAL INC

NASDAQ:OM (12/30/2025, 8:00:02 PM)

After market: 3.6006 -0.02 (-0.54%)

3.62

+0.08 (+2.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-10 2025-11-10/amc
Earnings (Next)01-05 2026-01-05/amc
Inst Owners94.39%
Inst Owner Change-4.56%
Ins Owners1.87%
Ins Owner Change0.07%
Market Cap65.70M
Revenue(TTM)120.07M
Net Income(TTM)-88.16M
Analysts83.08
Price Target16.07 (343.92%)
Short Float %13.19%
Short Ratio3.88
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.36%
Min EPS beat(2)-2.28%
Max EPS beat(2)16.99%
EPS beat(4)2
Avg EPS beat(4)-51.31%
Min EPS beat(4)-232.87%
Max EPS beat(4)16.99%
EPS beat(8)4
Avg EPS beat(8)-23.76%
EPS beat(12)5
Avg EPS beat(12)-18.58%
EPS beat(16)5
Avg EPS beat(16)-16.75%
Revenue beat(2)1
Avg Revenue beat(2)-1.87%
Min Revenue beat(2)-7.47%
Max Revenue beat(2)3.73%
Revenue beat(4)3
Avg Revenue beat(4)0.15%
Min Revenue beat(4)-7.47%
Max Revenue beat(4)3.86%
Revenue beat(8)4
Avg Revenue beat(8)-2.89%
Revenue beat(12)7
Avg Revenue beat(12)-1.9%
Revenue beat(16)9
Avg Revenue beat(16)-1.59%
PT rev (1m)0%
PT rev (3m)-38.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.26%
EPS NY rev (1m)-3.6%
EPS NY rev (3m)-3.6%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-18.66%
Revenue NY rev (1m)-5.95%
Revenue NY rev (3m)-5.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.55
P/FCF N/A
P/OCF N/A
P/B 0.46
P/tB 0.46
EV/EBITDA N/A
EPS(TTM)-10.32
EYN/A
EPS(NY)-2.74
Fwd EYN/A
FCF(TTM)-2.94
FCFYN/A
OCF(TTM)-2.91
OCFYN/A
SpS6.62
BVpS7.84
TBVpS7.84
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -31.8%
ROE -61.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.7%
FCFM N/A
ROA(3y)-47.4%
ROA(5y)-38.06%
ROE(3y)-228.02%
ROE(5y)-148.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y66.06%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12.63%
Cap/Sales 0.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.09
Quick Ratio 5.77
Altman-Z -4.95
F-Score6
WACC5.93%
ROIC/WACCN/A
Cap/Depr(3y)78.75%
Cap/Depr(5y)116.96%
Cap/Sales(3y)3.55%
Cap/Sales(5y)6.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.21%
EPS Next Y82.99%
EPS Next 2Y37.79%
EPS Next 3Y24.04%
EPS Next 5Y14.67%
Revenue 1Y (TTM)4.65%
Revenue growth 3Y3.48%
Revenue growth 5Y49.74%
Sales Q2Q%2.67%
Revenue Next Year3.61%
Revenue Next 2Y6.33%
Revenue Next 3Y4.68%
Revenue Next 5Y11.63%
EBIT growth 1Y45.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year46.16%
EBIT Next 3Y16.21%
EBIT Next 5Y15.24%
FCF growth 1Y63.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.67%
OCF growth 3YN/A
OCF growth 5YN/A

OUTSET MEDICAL INC / OM FAQ

What is the fundamental rating for OM stock?

ChartMill assigns a fundamental rating of 2 / 10 to OM.


What is the valuation status of OUTSET MEDICAL INC (OM) stock?

ChartMill assigns a valuation rating of 1 / 10 to OUTSET MEDICAL INC (OM). This can be considered as Overvalued.


How profitable is OUTSET MEDICAL INC (OM) stock?

OUTSET MEDICAL INC (OM) has a profitability rating of 1 / 10.


What is the financial health of OUTSET MEDICAL INC (OM) stock?

The financial health rating of OUTSET MEDICAL INC (OM) is 3 / 10.